Professional Activities
The IHS has a special professional Committee for the Ministry of Health "basket" for approval of novel drugs and technologies in the field of cardiology. We also perform professional screening and consultation for the Israel Ministry of Health. The IHS is responsible for the national Cardiology Board examination and certification, and for determining the curriculum for cardiology training. We have very close academic collaborations with the ESC and the ACC. The IHS has published 27 position papers on various aspects of cardiology and 15 guidelines (IHS usually adapts the guidelines published by the ESC).
Educational Activities
The IHS is strongly involved with cardiology education in Israel. We conduct an annual advanced 3-day cardiology course for senior residents as preparation for their final board examinations. This course consists of up-todate, state-of-the-art lectures in all aspects of cardiology, including case reviews. Also, an annual update day for community physicians is a great opportunity to involve family physicians in the latest advancements in the field of cardiology. 
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lowship at the Krannert Heart Institute in Indianapolis, Indiana). We also distribute supporting grants for young cardiologists who are presenting their original works at major cardiology scientific meetings such as the ESC, ACC, and AHA meetings. Several modest basic research grants are also provided by the IHS. The IHS also elects annually candidates for the Kellerman's basic research young investigator award, the Neufeld awards for the most important original publication and the most distinguished publication of the year, the Michele Mirowski award for excellence in cardiology, the Richard, Hilda and Ezra Meltzer Memorial award for the best publication in non-invasive cardiology, and the Daniel Shiran Memorial award for "the best" resident in cardiology.
Research and Scientific Activities
The Acute Coronary Syndrome Israeli Survey (ACSIS) is a 2-month biennial ACS Survey conducted since 2000 in all 26 cardiology departments in Israel. The objectives of these surveys are to assess the management and prognosis of patients with ACS in Israel, to assess guidelines' implementation in daily practice, and to compare the present practice of ACS management with data from previous surveys. Demographic, clinical, and outcome data are collected. Over the past 2 decades more than 100 peer-reviewed scientific papers have been published. We have shown a dramatic decrease in mortality from ACS from 2000 to 2010, because of the implementation of evidence-based therapies by all hospitals in Israel and the nation-wide 24/7 availability of primary percutaneous coronary intervention (PCI) for patients with STEMI. Figure 1 shows in-hospital mortality and 30-day mortality and MACE rates from 2000 to 2010 in patients admitted with ACS. In 2010, additional data on all cardiac interventions performed in patients were included in the main ACSIS (ACSIS-PCI). We were able to show a 30% rate of transradial access, 40% rate of drug-eluting stent use, and 50% rate of aspiration during primary PCI. Furthermore, the IHS (via its working groups) conducts several additional surveys and registries, including valvular and coronary intervention registries (with the ESC), heart failure survey, electrophysiology (EP) device registry, and transcatheter aortic valve implantation (TAVI) registry. The hallmark of the HIS' scientific activities is the annual 2-day meeting, which takes place in April-May with the collaboration of the Society of Cardio-Thoracic Surgery (www.israelheart.com). It is attended by approximately 1,500 cardiologists and health professionals. The meeting includes 3 very important joint sessions with the ESC, ACC and AFICARDIO (Association of France and Israeli Cardiologists). We are usually blessed with world-renowned guest speakers from Europe, USA, and Canada. The meeting also has a large industry exhibition, including the formal ESC booth (Figure 2) . 
